Safety and Efficacy of Topical Ofloxacin in Pediatric Otologic Conditions

Systemic Absorption and Pediatric Safety

• Topical fluoroquinolone ear drops (e.g., ofloxacin) exhibit negligible systemic absorption, which underlies their safety profile for children when used within the approved age ranges. [1][2]

• The American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) emphasizes that the localized drug concentration in the ear limits systemic exposure, supporting the use of ofloxacin in pediatric patients. 4

Use in Ears with Non‑Intact Tympanic Membranes

• Ofloxacin otic solution is specifically approved for ears with tympanostomy tubes or perforated tympanic membranes because clinical trials and animal studies have not demonstrated ototoxicity with this agent. [1][2]3

Avoidance of Ototoxic Aminoglycoside Drops

• The AAO‑HNS recommends that aminoglycoside‑containing ear drops (e.g., neomycin, neomycin‑polymyxin B‑hydrocortisone) should not be used in patients who have tympanic membrane perforations or tympanostomy tubes, due to the established risk of ototoxicity. [1][2]3